Sort
82,697 grants matching “vaccine development”
Novel IL-15 Superagonist Therapy for Bladder Cancer
$999,919Peter R Rhode · Altor Bioscience. Llc · R44 · FY2017 · CA
Cryopreservation and delivery of sporozoite vaccine
$999,910Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2009 · AI
RAISE: IHBEM: Modeling Dynamic Disease-Behavior Feedbacks for Improved Epidemic Prediction and Response
$999,908Lauren M Gardner · Johns Hopkins University · · FY2022 · MPS
Improved Influenza Vaccine Efficacy Through Infection Mimicry
$999,900Kathryn Kosuda · Vaxess Technologies, Inc. · R44 · FY2021 · AI
Clinical Development of Combination Plague/Smallpox Vaccine
$999,900Charalambos Partidos · Inviragen, Inc. · R44 · FY2010 · AI
Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts
$999,893Bernhard Josef Hering · University Of Minnesota · U01 · FY2015 · AI
Development of a Yellow Fever Vaccine for Vulnerable Population
$999,884Ian James Amanna · Najit Technologies, Inc. · R44 · FY2011 · AI
Intranasal Vaccine Against Lyme Disease
$999,881Maria Gomes-Solecki · Immuno Technologies, Inc. · R44 · FY2024 · AI
A genetically modified Plasmodium falciparum sporozoite vaccine attenuated at the late-liver stage
$999,880B. Kim Lee Sim · Sanaria, Inc. · R44 · FY2023 · AI
Microneedle Delivery of Zanamivir for the Treatment of Influenza Infections
$999,862Elke Lipka · Tsrl, Inc. · R44 · FY2022 · AI
Herpes Simplex Immunotherapeutic Vaccine
$999,845Sean M. Sullivan · Vical, Inc. · R42 · FY2009 · AI
Development and Experimental Verification of Fundamental Models to Enable Implementation of Microwave-Assisted Freeze Drying
$999,842Emily S Gong · Physical Sciences, Inc · U01 · FY2023 · FD
Advancing a Mucosal HSV-2 Vaccine Towards Clinical Trials
$999,834Kejian Yang · Biomedical Research Models, Inc. · R44 · FY2014 · AI
Strain-Independent Therapeutic Antibodies for Influenza
$999,820Lawrence Michael Kauvar · Trellis Bioscience, Inc. · R44 · FY2022 · AI
Pre-IND Development of an Arenavirus Antiviral
$999,816Gregory William Henkel · Arisan Therapeutics, Inc. · R44 · FY2021 · AI
MRI: Development of a fully automated, 1,000-MicroChemostat microfluidic system for parallel, independent, long-duration, machine-guided experiments
$999,810John P Wikswo · Vanderbilt University · · FY2021 · BIO
Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery
$999,781Barton F Haynes · Duke University · UM1 · FY2016 · AI
Recombinant Outer Membrane Vesicles as a Novel Adjuvant for a Malaria Vaccine
$999,762Christopher Locher · Versatope Therapeutics, Inc. · R44 · FY2024 · AI
Novel, Self-Applied MicroArray Patch (MAP) of Zanamivir for Treatment of the Flu
$999,746Elke Lipka · Tsrl, Inc. · R44 · FY2024 · AI
Immunity to Bacillus anthracis: Spore-Host Interactions
$999,723John Franklin Kearney · University Of Alabama At Birmingham · P01 · FY2007 · AI
Development of live attenuated respiratory syncytial virus vaccines with novel thermal stable fusion protein
$999,722Roderick Tang · Meissa Vaccines, Inc. · R44 · FY2018 · AI
A multivalent O-antigen bioconjugate vaccine for the prevention of Klebsiella pneumoniae infections
$999,717Christian Harding · Vaxnewmo, Llc · R42 · FY2025 · AI
Point-of-care lateral flow immunoassay for diagnosis of pertussis
$999,716Amanda Burnham-Marusich · Dxdiscovery, Inc. · R44 · FY2024 · AI
Preclinical development of novel small molecule malaria drugs that overcome drug
$999,700David H Peyton · Designmedix, Inc. · R42 · FY2015 · AI
Beginnings: Diversifying Talent in Advanced Biologics Manufacturing
$999,691Baley Reeves · Texas A&M Engineering Experiment Station · · FY2024 · TIP